McClung Nancy, Burnett Janet, Wejnert Cyprian, Markowitz Lauri E, Meites Elissa
Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Vaccine. 2020 Nov 3;38(47):7417-7421. doi: 10.1016/j.vaccine.2020.08.040. Epub 2020 Oct 10.
Men who have sex with men (MSM) are at high risk for infections and diseases caused by human papillomavirus (HPV), many of which are vaccine-preventable. In the United States, routine HPV vaccination has been recommended for adolescent males since 2011. This analysis evaluated self-reported receipt of ≥ 1 HPV vaccine dose by age group and HIV status among adult MSM using 2017 data from National HIV Behavioral Surveillance (NHBS) and compared the proportion vaccinated to prior years. Among 10,381 MSM aged ≥ 18 years, 17.9% of MSM overall and 28.4% of MSM living with HIV reported any HPV vaccination. Among 2,482 MSM aged 18-26 years, 32.8% overall and 51.3% living with HIV reported HPV vaccination. Since 2011, the proportion of MSM aged 18-26 years reporting HPV vaccination has increased over six-fold. As vaccinated adolescents age into young adults, coverage will continue to increase overall, including among MSM.
男男性行为者（MSM）感染人乳头瘤病毒（HPV）引发的感染和疾病风险很高，其中许多疾病可通过疫苗预防。在美国，自2011年起就建议对青春期男性进行常规HPV疫苗接种。本分析利用国家艾滋病行为监测（NHBS）2017年的数据，评估了成年男男性行为者按年龄组和艾滋病毒感染状况自我报告的≥1剂HPV疫苗接种情况，并将接种比例与往年进行了比较。在10381名年龄≥18岁的男男性行为者中，总体上17.9%的男男性行为者以及28.4%的艾滋病毒感染者报告接种过任何HPV疫苗。在2482名年龄在18 - 26岁的男男性行为者中，总体上32.8%以及51.3%的艾滋病毒感染者报告接种过HPV疫苗。自2011年以来，报告接种HPV疫苗的18 - 26岁男男性行为者比例增长了六倍多。随着接种疫苗的青少年步入青年期，总体接种覆盖率将持续上升，包括男男性行为者在内。
